Combination of a PDE inhibitor and an NSAID

摘要

Disclosed are pharmaceutical combinations comprising, the PDE4 inhibitor Roflumilast, and a conventional NSAID selected from Acetylsalicylic acid, Diclofenac, Ibuprofen, Indometacin, Naproxen, an Piroxicam. The combinations are used in the manufacture of medicaments for the treatment of rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus or juvenile arthritis.